ARQULE, INC - Product Pipeline Review - Q2 2011

Global Markets Direct, July 2011, Pages: 58

ARQULE, INC – Product Pipeline Review – Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, “ARQULE, INC - Product Pipeline Review - Q2 2011” provides data on the ARQULE, INC’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ARQULE, INC’s corporate website, SEC filings, investor presentations and featured press releases, both from ARQULE, INC and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- ARQULE, INC - Brief ARQULE, INC overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of ARQULE, INC human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of ARQULE, INC with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the ARQULE, INC’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate ARQULE, INC’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of ARQULE, INC in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the ARQULE, INC’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with ARQULE, INC.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of ARQULE, INC and identify potential opportunities in those areas.

List of Tables
List of Figures
ARQULE, INC Snapshot
ARQULE, INC Overview
Key Information
Key Facts
ARQULE, INC – Research and Development Overview
Key Therapeutic Areas
ARQULE, INC – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
ARQULE, INC – Pipeline Products Glance
ARQULE, INC Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
ARQULE, INC–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
ARQULE, INC – Drug Profiles
ARQ 197
Product Description
Mechanism of Action
R&D Progress
ARQ 197 + Cetuximab + Irinotecan
Product Description
Mechanism of Action
R&D Progress
ARQ 501
Product Description
Mechanism of Action
R&D Progress
ARQ 501 + Gemcitabine
Product Description
Mechanism of Action
R&D Progress
ARQ 197 + Sorafenib
Product Description
Mechanism of Action
R&D Progress
ARQ 501 + Docetaxel
Product Description
Mechanism of Action
R&D Progress
ARQ 621
Product Description
Mechanism of Action
R&D Progress
ARQ 736
Product Description
Mechanism of Action
R&D Progress
ARQ 087
Product Description
Mechanism of Action
R&D Progress
Non-ATP Competitive Kinase Inhibitors
Product Description
Mechanism of Action
R&D Progress
ARQULE, INC – Pipeline Analysis
ARQULE, INC – Pipeline Products by Therapeutic Class
ARQULE, INC - Pipeline Products By Target
ARQULE, INC – Pipeline Products by Route of Administration
ARQULE, INC – Pipeline Products by Molecule Type
ARQULE, INC – Recent Pipeline Updates
ARQULE, INC - Dormant Projects
ARQULE, INC - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
ARQ 171
ARQULE, INC – Company Statement
ARQULE, INC – Locations And Subsidiaries
Head Office
Financial Deals Landscape
ARQULE, INC, Deals Volume Summary, 2004 to YTD 2011
ARQULE, INC, Deals Summary By Region, 2004 to YTD 2011
ARQULE, INC, Deals Summary, 2004 to YTD 2011
ARQULE, INC Detailed Deal Summary
Equity Offering
ArQule Completes Public Offering Of $58 Million
ArQule Completes Public Offering Of $30 Million
ArQule Enters Into An Agreement With Daiichi Sankyo
ArQule Enters Into Research Agreement With Boston Biomedical
Roche Enters Into Co-Development Agreement With ArQule
Licensing Agreements
ArQule Enters Into Licensing Agreement With Daiichi Sankyo
Kyowa Hakko Kogyo Enters Into Licensing Agreement With ArQule
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
ARQULE, INC – Pipeline by Therapy Area and Indication, 2011
ARQULE, INC – Pipeline by Stage of Development, 2011
ARQULE, INC – Monotherapy Products in Pipeline, 2011
ARQULE, INC – Combination Treatment Modalities in Pipeline, 2011
ARQULE, INC - Phase II, 2011
ARQULE, INC - Phase I, 2011
ARQULE, INC - Pipeline By Therapeutic Class, 2011
ARQULE, INC - Pipeline By Target, 2011
ARQULE, INC – Pipeline By Route of Administration, 2011
ARQULE, INC – Pipeline By Molecule Type, 2011
ARQULE, INC – Recent Pipeline Updates, 2011
ARQULE, INC - Dormant Developmental Projects, 2010
ARQULE, INC - Discontinued Pipeline Products, 2010
ARQULE, INC, Deals Summary, 2004 to YTD 2011
ARQULE, INC, Deals Summary by Region, 2004 to YTD 2011
ARQULE, INC, Deals Summary, 2004 to YTD 2011

List of Figures
ARQULE, INC – Pipeline by Therapy Area and Indication, 2011
ARQULE, INC – Pipeline by Stage of Development, 2011
ARQULE, INC – Monotherapy Products in Pipeline, 2011
ARQULE, INC – Combination Treatment Modalities in Pipeline, 2011
ARQULE, INC – Pipeline By Therapeutic Class, 2011
ARQULE, INC - Pipeline By Target, 2011
ARQULE, INC – Pipeline By Route of Administration, 2011
ARQULE, INC – Pipeline By Molecule Type, 2011

Customers who bought this item also bought

• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• SunGard - Profile - US
• Scientific Games Corporation - Company Analysis
• Ixia - Company Analysis
• eBay - Strong Execution
• Accenture - Profile - US
• Dell - Profile - US
• HP - Profile - US